Revvity Inc
NYSE:RVTY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Revvity Inc (RVTY) under the Base Case is USD per share. Compared with the current market price of 155.11 USD, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Revvity Does
Revvity makes tools and tests used in laboratories that study biology and diagnose disease. Its products include laboratory instruments, reagents, assay kits, software, and related services that help customers measure biological signals, run genetic and biochemical tests, and analyze results. The company serves drug developers, biotech and academic research labs, and clinical and public health laboratories.
- Headquarters
- United States of America US
- Employees
- 11 000
- IPO date
- Jul 6, 1965
Revvity has no economic moat
Customers can choose among many suppliers because research tools and diagnostic products compete on price, service, technology, availability, quality and reliability—not because a supplier’s product becomes more valuable as more labs use it. Revvity’s patents and product names support particular offerings, but its disclosures do not show a company-wide lock on customers or a brand premium that keeps rivals from competing.
Read the full moat analysis
Revenue & Expenses Breakdown
Revvity Inc
Earnings Waterfall
Revvity Inc
What is the Intrinsic Value of one RVTY stock?
The intrinsic value for Revvity Inc (RVTY) under the Base Case is USD.
Is RVTY stock undervalued or overvalued?
Compared with the current market price of 155.11 USD, the stock appears .